About
Contact
Subscribe
e-Edition

Make Home Page

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter

- Site search

Home
News
Sports
- Local Sports
- National Sports
Business
Opinion
A & E
Life
Features & Magazines
Classifieds
Weather
Obituaries
Last Chance Auction 40% Off

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

NovoCure Limited - Ordinary Shares (NQ:NVCR)

18.01 -0.09 (-0.50%)

Streaming Delayed Price Updated: 3:27 PM EDT, May 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NovoCure Limited - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9

...

20 21 Next >

NovoCure (NVCR) Q4 2023 Earnings Call Transcript ↗

February 22, 2024

NVCR earnings call for the period ending December 31, 2023.

Via The Motley Fool

Topics Earnings

Novocure Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update

February 22, 2024

From Novocure

Via Business Wire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 18, 2024

Via Benzinga

Why Is Cancer Focused Novocure Stock Trading Higher Today? ↗

January 18, 2024

Novocure's TTFields therapy gains FDA acceptance for non-small cell lung cancer treatment after platinum-based therapy. PMA filing under FDA review. Decision expected in 2H 2024.

Via Benzinga

Fastenal Posts Upbeat Earnings, Joins NovoCure, Taiwan Semiconductor Manufacturing And Other Big Stocks Moving Higher On Thursday ↗

January 18, 2024

U.S. stocks traded mixed, with the Dow Jones index falling around 50 points on Thursday. Shares of Fastenal Company (NASDAQ: FAST) rose during Thursday’s session after the company reported...

Via Benzinga

Topics Stocks

Is Novocure Stock a Buy? ↗

November 03, 2023

The stock isn't far from its 52-week low.

Via The Motley Fool

Earnings Scheduled For February 22, 2024 ↗

February 22, 2024

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on revenue of $260.00 million.

Via Benzinga

NovoCure Ltd. (NASDAQ: NVCR) Leading the Way in Thursday Trading Based on Percentage Gain

January 18, 2024

Via Investor Brand Network

AI Drives Tech Rebound, Oil Soars, Bitcoin Tumbles: What's Driving Markets Thursday? ↗

January 18, 2024

During midday Thursday trading in New York, U.S. stocks displayed mixed performance, with the technology sector outperforming others as investors maintained a bullish outlook on artificial...

Via Benzinga

Topics Artificial Intelligence

Novocure Announces FDA Acceptance of the PMA Application for TTFields Therapy in Non-Small Cell Lung Cancer

January 18, 2024

From Novocure

Via Business Wire

Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 10, 2024

Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter results.

Via Benzinga

Veradigm, Aehr Test Systems, Saratoga Investment And Other Big Stocks Moving Lower On Wednesday ↗

January 10, 2024

U.S. stocks traded slightly higher, with the Dow Jones index gaining over 20 points on Wednesday. Shares of Veradigm Inc. (NASDAQ: MDRX) shares fell sharply during Wednesday’s session.

Via Benzinga

Topics Stocks

Novocure Announces Last Patient Enrolled in Phase 3 TRIDENT Trial in Newly Diagnosed Glioblastoma

January 09, 2024

From Novocure

Via Business Wire

Novocure Announces Preliminary Full Year and Fourth Quarter 2023 Net Revenues and Provides Company Update

January 08, 2024

From Novocure

Via Business Wire

Novocure Appoints Dr. Nicolas Leupin as Chief Medical Officer

January 04, 2024

From Novocure

Via Business Wire

Novocure to Participate in 42nd Annual J.P. Morgan Healthcare Conference

December 27, 2023

From Novocure

Via Business Wire

7 Nasdaq Stocks Down 59% Set to Soar at Least 141% ↗

December 12, 2023

Wall Street always think companies are high-growth potential stocks but a little circumspection is required before buying

Via InvestorPlace

FCEL Stock Alert: FuelCell Energy Announces AI Deal With IBM ↗

November 28, 2023

FuelCell Energy stock is climbing higher on Tuesday as investors in FCEL celebrate the company signing a deal with IBM!

Via InvestorPlace

Topics Artificial Intelligence

Novocure Layoffs 2023: What to Know About the Latest NVCR Job Cuts ↗

November 28, 2023

Novocure layoffs are coming for 13% of the company's workers as it seeks to reduce its headcount by 200 people to reduce costs.

Via InvestorPlace

Topics Workforce

Novocure Announces Portfolio Prioritization and Strategic Restructuring Plan Focused on Near-term Growth Drivers and an Accelerated Path to Profitability

November 28, 2023

From Novocure

Via Business Wire

Novocure to Participate in 35th Annual Piper Sandler Healthcare Conference

November 21, 2023

From Novocure

Via Business Wire

Novocure Announces Presentations on Tumor Treating Fields Therapy, Including New Clinical Data and Real-World Evidence, at 2023 Society for Neuro-Oncology Annual Meeting

November 10, 2023

From Novocure

Via Business Wire

Why Novocure Stock Was Sick Today ↗

October 26, 2023

Investors weren't particularly pleased with the company's third-quarter performance.

Via The Motley Fool

NovoCure (NVCR) Q3 2023 Earnings Call Transcript ↗

October 26, 2023

NVCR earnings call for the period ending September 30, 2023.

Via The Motley Fool

Topics Earnings

Novocure Reports Third Quarter 2023 Financial Results

October 26, 2023

From Novocure

Via Business Wire

Novocure Announces Presence at European Society for Medical Oncology (ESMO) Congress 2023

October 15, 2023

From Novocure

Via Business Wire

Novocure and Stanford School of Medicine to Establish Tumor Treating Fields Research Program

October 12, 2023

From Novocure

Via Business Wire

NovoCure Limited (NASDAQ:NVCR) Long Term Shareholder Notice: Investigation of Potential Wrongdoing ↗

October 10, 2023

San Diego, CA -- (SBWIRE) -- 10/10/2023 -- An investigation was announced for investors in shares of NovoCure Limited (NASDAQ:NVCR) concerning potential breaches of fiduciary duties by certain...

Via SBWire

10 Health Care Stocks Whale Activity In Today's Session ↗

October 05, 2023

Via Benzinga

Novocure to Report Third Quarter 2023 Financial Results

October 02, 2023

From Novocure

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

20 21 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Opinion
Photo Galleries
Videos
Local Events
Classifieds
Obituaries

Services

About
Contact
Personnel
Advertise
Subscription Services
Promote Your Event
Dealer Locations
Email Alerts
Submission Forms

Contact Information

chroniclejournal.com
75 S. Cumberland Street
Thunder Bay, ON P7B 1A3
Phone: 807 343 6200
Email: circulation@chroniclejournal.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

NovoCure Limited - Ordinary Shares (NQ:NVCR)

All News about NovoCure Limited - Ordinary Shares

Sections

Services

Contact Information

Follow Us